Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Applied Genetic Technologies Corp    AGTC

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/16/2017 11/17/2017 11/20/2017 11/21/2017 11/22/2017 Date
3.8(c) 3.95(c) 3.8(c) 3.8(c) 3.85(c) Last
75 224 96 055 53 694 36 955 81 907 Volume
0.00% +3.95% -3.80% 0.00% +1.32% Change
More quotes
Financials ($)
Sales 2018 33,2 M
EBIT 2018 -18,4 M
Net income 2018 -17,6 M
Debt 2018 -
Yield 2018 -
Sales 2019 34,1 M
EBIT 2019 -33,7 M
Net income 2019 -33,3 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 2,10x
Capi. / Sales2019 2,05x
Capitalization 69,7 M
More Financials
Company
Applied Genetic Technologies Corp. is a clinical-stage biotechnology company, which engages in the development of gene therapy products designed to transform the lives of patients with severe diseases in ophthalmology.Its product candidates are designed to treat X-linked retinoschisis,... 
More about the company
Surperformance© ratings of Applied Genetic Technologi
Trading Rating : Investor Rating :
More Ratings
Latest news on APPLIED GENETIC TECHNOLOGI
11/07 APPLIED GENETIC TECHNOLOGIES : posts 1Q loss
11/07 APPLIED GENETIC TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL..
11/07 APPLIED GENETIC TECHNOLOGIES CORP : Results of Operations and Financial Conditio..
11/07 AGTC Announces Financial Results and Business Update for the Quarter Ended Se..
10/31 AGTC to Host First Quarter Financial Results Conference Call and Webcast on N..
10/06 AGTC and the Medical College of Wisconsin Announce Publication of Natural His..
10/02 APPLIED GENETIC TECHNOLOGIES CORP : Earnings Review and Free Research Report: Ap..
09/29 AGTC to Present at Upcoming Gene Therapy Conferences
09/20 AGTC to Present at Upcoming Conferences
09/14 APPLIED GENETIC TECHNOLOGIES CORPORA : AGTC) Files An 8-K Results of Operations ..
More news
Sector news : Bio Therapeutic Drugs
11/22 U.S. FDA approves first two-drug HIV regimen in win for GSK
11/16 Recovery rally for European stocks leaves oil sector behind
11/13 Poor earnings updates keep European shares at seven-week low
11/13DJNOVARTIS : Vision Drug Shows Positive Results in Phase 3 Trials
11/03 Prosecutors search Metro offices in insider trading probe
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
11/13 EDITORS' PICKS DAILY : Is Downsizing A Fad?
11/10 APPLIED GENETIC TECHNOLOGIES CORP. : A Forgotten Net-Net With Clear Upside Catal..
11/07 Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q1 2018 Results - Earn..
11/07 Applied Genetic beats by $0.01, beats on revenue
11/06 Notable earnings after Tuesday?s close
Chart APPLIED GENETIC TECHNOLOGI
Duration : Period :
Applied Genetic Technologi Technical Analysis Chart | AGTC | US03820J1007 | 4-Traders
Technical analysis trends APPLIED GENETIC TECHNOLOGI
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 8,14 $
Spread / Average Target 112%
EPS Revisions
Managers
NameTitle
Susan B. Washer President, Chief Executive Officer & Director
William A. Sullivan Chief Financial Officer
Mark S. Shearman Chief Scientific Officer & Vice President
Matthew Feinsod Chief Medical Officer
James Rosen Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
APPLIED GENETIC TECHNOLOGIES CORP-59.36%70
GILEAD SCIENCES1.69%95 098
REGENERON PHARMACEUTICALS4.73%41 637
VERTEX PHARMACEUTICALS99.59%37 187
GENMAB4.94%11 692
EXELIXIS, INC.74.72%7 731